Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomics: New Developments in Target Discovery.

Judit M. Nagy, Katherine A. Brown

    Drug News & Perspectives
    |April 5, 2003
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    New drug discovery and development in India.

    Drug news & perspectives·2013
    Same journal

    Are we living in the end of the blockbuster drug era?

    Drug news & perspectives·2010
    Same journal

    Molecule of the Month. TAK-875.

    Drug news & perspectives·2010
    Same journal

    Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.

    Drug news & perspectives·2010
    Same journal

    Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?

    Drug news & perspectives·2010
    Same journal

    Trioxaquines: hybrid molecules for the treatment of malaria.

    Drug news & perspectives·2010
    See all related articles

    This meeting highlighted proteomics advancements in drug discovery, discussing challenges and the growing roles of bioanalysis, bioinformatics, and pharmacogenomics.

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Genomics

    Background:

    • A meeting was held on September 19, 2002, in London, UK.
    • The event was a collaboration between the Society for Medicines Research and the Royal Society for Chemistry's Biological and Medicinal Chemistry sector.
    • The focus was on the emerging field of proteomics in drug discovery.

    Purpose of the Study:

    • To provide an overview of the current progress in proteomics for drug discovery.
    • To discuss the challenges encountered in silico, in vitro, and in vivo.
    • To consider the contributions of bioanalysis, bioinformatics, and pharmacogenomics.

    Main Methods:

    • Expert presentations and discussions.
    • Review of current research and industry trends.

    Related Experiment Videos

  • Consideration of interdisciplinary approaches.

    • Main Results:

    • An up-to-date overview of proteomics in drug discovery was presented.
    • Key challenges in applying proteomics across different experimental settings were identified.
    • The increasing importance of supporting fields was emphasized.

    Conclusions:

    • Proteomics is a rapidly advancing field with significant potential in drug discovery.
    • Overcoming in silico, in vitro, and in vivo challenges is crucial for successful implementation.
    • Integration with bioanalysis, bioinformatics, and pharmacogenomics is essential for maximizing the impact of proteomics.